← Leaderboards
Adina Zeidler
University Of Southern California
$573,951
Attributed
$573,951
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$573,951 · 3
By mechanism
M01$573,951 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of Southern California
Same institution · by research overlap
- Thomas A Buchanan$121,360,154
- Mariana C Stern$2,406,912
- Richard N. Bergman$24,561,906
- Peter Cawood Butler$14,117,119
- Mohammed F Saad$15,433,253
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectInsulin Dependent Diabetes MellitusClinical ResearchInsulinOutcomes ResearchHuman Therapy EvaluationHormone TherapyDrug ToleranceEpidemiologyFamily GeneticsImmunosuppressionMexican AmericansOral AdministrationPancreatic IsletsChemopreventionPediatric PharmacologyChild (0-11)Clinical TrialsCytotoxicityDiabetes Mellitus GeneticsDiabetes Mellitus TherapyDisease /Disorder Prevention /Control
Grant awards (15)
GENETICS OF IDDM IN MEXICAN AMERICAN FAMILIES$0
M01 · FY2002 · RR
FEASIBILITY OF ORAL INSULIN THERAPY TO DELAY BETA CELL DESTRUCTION$0
M01 · FY2002 · RR
DIABETES PREVENTION TRIAL--TYPE I DIABETES$0
M01 · FY2002 · RR
DIABETES PREVENTION TRIAL--TYPE I DIABETES$155,764
M01 · FY2001 · RR
GENETICS OF IDDM IN MEXICAN AMERICAN FAMILIES$155,764
M01 · FY2001 · RR
FEASIBILITY OF ORAL INSULIN THERAPY TO DELAY BETA CELL DESTRUCTION$155,764
M01 · FY2001 · RR
DIABETES PREVENTION TRIAL--TYPE I DIABETES$0
M01 · FY2001 · RR
FEASIBILITY OF ORAL INSULIN THERAPY TO DELAY BETA CELL DESTRUCTION$0
M01 · FY2001 · RR
GENETICS OF IDDM IN MEXICAN AMERICAN FAMILIES$0
M01 · FY2001 · RR
FEASIBILITY OF ORAL INSULIN THERAPY TO DELAY BETA CELL DESTRUCTION$35,553
M01 · FY2000 · RR
DIABETES PREVENTION TRIAL--TYPE I DIABETES$35,553
M01 · FY2000 · RR
GENETICS OF IDDM IN MEXICAN AMERICAN FAMILIES$35,553
M01 · FY2000 · RR
DIABETES PREVENTION TRIAL--TYPE I DIABETES$0
M01 · FY2000 · RR
GENETICS OF IDDM IN MEXICAN AMERICAN FAMILIES$0
M01 · FY2000 · RR
FEASIBILITY OF ORAL INSULIN THERAPY TO DELAY BETA CELL DESTRUCTION$0
M01 · FY2000 · RR